CD81 and acute myeloid leukemia: In addition, CD19 (p = 2.52 × 10−6), CD7 (p = 7.27 × 10−6), CD81 (p = 1.67 × 10−5), CD276 (p = 1.67 × 10−4), and CD70 (p = 1.80 × 10−4), were each significantly differentially expressed between poor and good risk subgroups in adult AML.